Interferon beta treatment of multiple sclerosis increases serum interleukin-7

Lundstrom Wangko; Hermanrud Christina; Sjostrand Maria; Brauner Susanna; Wahren-Herlenius Marie; Olsson Tomas; Karrenbauer Virginija; Hillert Jan; Fogdell-Hahn Anna

首页> 外文期刊>Multiple sclerosis: clinical and laboratory research >Interferon beta treatment of multiple sclerosis increases serum interleukin-7

【24h】

Interferon beta treatment of multiple sclerosis increases serum interleukin-7

机译：干扰素β治疗多发性硬化症可增加血清白介素7

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Interleukin-7 (IL-7) is a non-redundant cytokine for T-cell development and survival. The IL-7 signaling pathway has been genetically and functionally associated with several autoimmune diseases including multiple sclerosis (MS).

机译：背景：白细胞介素7（IL-7）是用于T细胞发育和存活的非冗余细胞因子。 IL-7信号通路在遗传和功能上与几种自身免疫性疾病（包括多发性硬化症（MS））相关。

著录项

来源
《Multiple sclerosis: clinical and laboratory research》 |2014年第13期|共10页
作者
Lundstrom Wangko; Hermanrud Christina; Sjostrand Maria; Brauner Susanna; Wahren-Herlenius Marie; Olsson Tomas; Karrenbauer Virginija; Hillert Jan; Fogdell-Hahn Anna;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类神经病学与精神病学;
关键词
Multiple sclerosis; immunology; interferon beta; natalizumab;

机译：多发性硬化症;免疫学;β-干扰素;那他珠单抗;

相似文献

外文文献
中文文献
专利

1. Interferon beta treatment of multiple sclerosis increases serum interleukin-7 [J] . Lundstrom Wangko, Hermanrud Christina, Sjostrand Maria, Multiple sclerosis: clinical and laboratory research . 2014,第13期

机译：干扰素β治疗多发性硬化症可增加血清白介素7
2. Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy. [J] . Fainardi E, Rizzo R, Melchiorri L, Journal of Neuroimmunology: Official Bulletin of the Research Committee on Neuroimmunology of the World Federation of Neurology . 2004,第1a2期

机译：复发缓解型多发性硬化症患者中干扰素-β1b治疗的有益作用与治疗前3个月血清可溶性HLA-1分子水平的升高有关。
3. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and t [J] . Nicoletti F, Di Marco-R, Patti F, Cytokine . 2000,第6期

机译：干扰素（IFN）-beta1B对复发缓解型多发性硬化症患者的短期治疗可在不显着改变IL-1beta，IL-2， IL-4和t
4. Efficiency of different chitosan and its derivative nanoparticles for delivery of recombinant plasmid of Tibetan pig interleukin-7 gene and regulation effect in vivo on immune responses of mice [C] . Xiaoping Wan, Xiao Yang, Jianling Chen, National SBIR/STTR conference;Annual nanotech conference and expo;Annual TechConnect world innovation conference expo . 2015

机译：不同壳聚糖及其衍生物纳米颗粒对藏猪白细胞介素7基因重组质粒的传递效率及体内对小鼠免疫应答的调节作用
5. Immunobiological studies of interferons in multiple sclerosis. [D] . Nguyen, Linh Thuy. 2001

机译：干扰素在多发性硬化症中的免疫生物学研究。
6. Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis after Interferon Beta and Melatonin Treatment [O] . Monika Adamczyk-Sowa, Sabina Galiniak, Ewa Żyracka, 2017

机译：干扰素β和褪黑激素治疗后多发性硬化中血清蛋白的氧化修饰
7. Interferon-beta, but not Glatiramer Acetate treatment induces gender-specific increase in BDNF serum levels in relapsing-remitting multiple sclerosis female patients [O] . Arianna Sartori, Giuliana Metelli, Alessio Polacchini, 2019

机译：干扰素β，但不是Glatizamer醋酸酯治疗在复发依赖于复发多发性硬化女性患者的BDNF血清水平中诱导性别特异性增加

Interferon beta treatment of multiple sclerosis increases serum interleukin-7

摘要

著录项

相似文献

相关主题

期刊订阅